8043B |
Postmortem, Prescription Screen w/Vitreous Alcohol, Blood (Forensic) |
8052FL |
Postmortem, Expanded, Fluid (Forensic) |
8052TI |
Postmortem, Expanded, Tissue (Forensic) |
8062FL |
Postmortem, Expanded w/o Alcohol, Fluid (Forensic) |
8062TI |
Postmortem, Expanded w/o Alcohol, Tissue (Forensic) |
8064B |
Postmortem BHB and Alcohol Profile, Blood (Forensic) |
8092B |
Postmortem, Prescription Drugs Screen, Blood (Forensic) |
8092FL |
Postmortem, Prescription Drugs Screen, Fluid (Forensic) |
8092SP |
Postmortem, Prescription Drugs Screen, Serum/Plasma (Forensic) |
8092TI |
Postmortem, Prescription Drugs Screen, Tissue (Forensic) |
8092U |
Postmortem, Prescription Drugs Screen, Urine (Forensic) |
8104B |
Postmortem, Fire Death Screen, Blood (Forensic) |
8620ME |
Barbiturates Panel (Qualitative), Meconium |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9329ME |
Benzodiazepines Panel (Qualitative), Meconium |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |